MCID: PLY020
MIFTS: 46

Polyradiculoneuropathy malady

Category: Neuronal diseases

Aliases & Classifications for Polyradiculoneuropathy

About this section

Aliases & Descriptions for Polyradiculoneuropathy:

Name: Polyradiculoneuropathy 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:4308
SNOMED-CT59 128078004
MeSH36 D011129
UMLS65 C0032587

Summaries for Polyradiculoneuropathy

About this section
Wikipedia:68 Polyradiculoneuropathy describes a condition in which polyneuropathy and polyradiculopathy occur... more...

MalaCards based summary: Polyradiculoneuropathy is related to prolymphocytic leukemia and neuropathy, inflammatory demyelinating. An important gene associated with Polyradiculoneuropathy is PMP22 (Peripheral Myelin Protein 22), and among its related pathways are Cytokines and Inflammatory Response and Immune response_IL-12 signaling pathway. Affiliated tissues include thyroid, brain and t cells, and related mouse phenotypes are liver/biliary system and tumorigenesis.

Related Diseases for Polyradiculoneuropathy

About this section

Diseases related to Polyradiculoneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 135)
idRelated DiseaseScoreTop Affiliating Genes
1prolymphocytic leukemia30.4MPZ, PMP22
2neuropathy, inflammatory demyelinating30.4MPZ, PMP22
3neuritis30.2MAG, PMP22
4viral hepatitis28.9HLA-DRB1, IFNG, STAT1, STAT3
5hepatitis b28.6ALB, STAT1, STAT3
6demyelinating polyneuropathy27.1ALB, CXCL12, IFNG, MPZ, PMP22, PRF1
7chronic inflammatory demyelinating polyradiculoneuropathy12.2
8polyradiculoneuropathy associated with igg/iga/igm monoclonal gammopathy without known antibodies11.9
9chronic inflammatory demyelinating polyneuropathy11.5
10guillain-barre syndrome11.4
11subacute inflammatory demyelinating polyneuropathy11.1
12congenital symblepharon10.7MPZ, PMP22
13charcot-marie-tooth neuropathy type 2a10.7MPZ, PMP22
14anal colloid adenocarcinoma10.6MPZ, PMP22
15neuropathy, recurrent, with pressure palsies10.6MPZ, PMP22
16askin's tumor10.6ALB, IFNG
17central nervous system origin vertigo10.6MPZ, PMP22
18goodpasture syndrome10.6ALB, IFNG
19non-distal monosomy 10q10.6HLA-DRB1, IFNG
20red cell phospholipid defect with hemolysis10.6HLA-DRB1, IFNG
21metanephric adenoma10.5HLA-DRB1, MPZ
22collagenous colitis10.5HLA-DRB1, IFNG
23hypercementosis10.5HLA-DRB1, IFNG
24infertility10.5IFNG, TBX21
25pulmonary nodular lymphoid hyperplasia10.4HLA-DRB1, IFNG
26hemorrhagic proctocolitis10.4HLA-DRB1, IFNG
27niemann-pick disease, type b10.4MAG, MPZ
28cryptosporidiosis10.4HLA-DRB1, IFNG
29photokeratitis10.3IFNG, STAT1
30cervix melanoma10.3ALB, IFNG
31hepatoid adenocarcinoma10.2HLA-DRB1, IFNG
32cytoplasmic body myopathy10.2CXCL12, HLA-DRB1, IFNG
33wandering spleen10.2MAG, MPZ
34angioid streaks10.2ALB, HLA-DRB1, STAT3
35htlv-1 associated myelopathy10.2MAG, MPZ, PMP22
36gastric antral vascular ectasia10.2MAG, MPZ, PMP22
37neuropathy10.2
38bird fancier's lung10.2MAG, MPZ, PMP22
39trichosporonosis10.1IFNG, STAT1
40macular keratitis10.1COL6A1, PMP22
41common peroneal nerve lesion10.1COL6A1, PMP22
42lupus erythematosus10.1
43spastic paraplegia 2, x-linked10.1MAG, MPZ
44dentin dysplasia10.1ALB, IFNG, STAT1
45systemic lupus erythematosus10.1
46hepatitis c virus10.1HLA-DRB1, IFNG, STAT3
47vulvar disease10.0IFNG, STAT1, STAT3
48reflex sympathetic dystrophy10.0IFNG, MPZ, PMP2, PMP22
49hairy cell leukemia of spleen10.0HLA-DRB1, IFNG, STAT1
50lymphoma10.0

Graphical network of the top 20 diseases related to Polyradiculoneuropathy:



Diseases related to polyradiculoneuropathy

Symptoms for Polyradiculoneuropathy

About this section

Drugs & Therapeutics for Polyradiculoneuropathy

About this section

Drugs for Polyradiculoneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 54)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
alemtuzumabapproved, investigationalPhase 4302216503-57-0
Synonyms:
Campath
 
Lemtrada
Mabcampath
alemtuzumab
2Rho(D) Immune GlobulinPhase 4, Phase 3, Phase 2206
3Immunoglobulins, IntravenousPhase 4, Phase 3, Phase 2211
4Immunologic FactorsPhase 4, Phase 3, Phase 218483
5ImmunoglobulinsPhase 4, Phase 3, Phase 24477
6AntibodiesPhase 4, Phase 3, Phase 24477
7
PrednisoneapprovedPhase 3126753-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
8
Mycophenolate mofetilapproved, investigationalPhase 3898128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate Mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
9
Mycophenolic acidapprovedPhase 389824280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
 
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic Acid
Mycophenolsaeure
Myfortic
10
Glycineapproved, nutraceuticalPhase 39456-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
11Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
12HormonesPhase 3, Phase 211748
13Contraceptives, OralPhase 3, Phase 23734
14Anti-Inflammatory AgentsPhase 38478
15Immunoglobulin GPhase 3146
163,4-diaminopyridinePhase 319
17Antineoplastic Agents, HormonalPhase 34256
18glucocorticoidsPhase 33896
19Hormone AntagonistsPhase 3, Phase 210002
20Immunosuppressive AgentsPhase 3, Phase 210422
21Pharmaceutical SolutionsPhase 3, Phase 27004
22Antibiotics, AntitubercularPhase 35971
23Anti-Bacterial AgentsPhase 39140
24Fingolimod HydrochloridePhase 386
25
DalfampridineapprovedPhase 262504-24-51727
Synonyms:
.gamma.-Aminopyridine
275875_ALDRICH
36687_FLUKA
36687_RIEDEL
4 AP
4 Aminopyridine
4 Aminopyridine Sustained Release
4-AP
4-Aminopyridine
4-Aminopyridine 10
4-Aminopyridine Sustained Release
4-Pyridinamine
4-Pyridylamine
4-aminopyridine
5-22-09-00106 (Beilstein Handbook Reference)
504-24-5
A 0152
A0414
A78403_ALDRICH
AB1004971
AC-907/25014071
AC1L1C3R
AC1Q52BM
AI3-52547
AKOS000119896
Amaya
Amino-4 pyridine
Amino-4-Pyridine
Ampydin
Ampyra
Avitrol
Avitrol 200
BB_SC-6974
BRN 0105782
BSPBio_001562
Bio1_000353
Bio1_000842
Bio1_001331
Bio2_000282
Bio2_000762
C13728
C5H6N2
CHEBI:34385
CHEMBL284348
CID1727
Caswell No. 038
Compound 1861
D015761
D04127
Dalfampridine
DivK1c_000572
EINECS 207-987-9
EL-970
EPA Pesticide Chemical Code 069201
EU-0100032
FT-0083754
Fampridina
Fampridine
Fampridine (USAN/INN)
Fampridine SR
Fampridine [USAN:INN]
Fampridine-PR
Fampridine-SR
Fampridinum
Fampyra
HC150041
HMS1361O04
HMS1791O04
HMS1921H15
HMS1989O04
HMS2092F05
HMS501M14
HSDB 6037
IDI1_000572
IDI1_034032
InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7
 
KBio1_000572
KBio2_000282
KBio2_000635
KBio2_002850
KBio2_003203
KBio2_005418
KBio2_005771
KBio3_000563
KBio3_000564
KBio3_001888
KBioGR_000282
KBioGR_001505
KBioSS_000282
KBioSS_000635
LS-130202
Lopac-A-0152
Lopac0_000032
MLS000069400
Mi-W-3
MolPort-000-146-022
N07XX07
NCGC00015009-01
NCGC00015009-03
NCGC00015009-12
NCGC00024890-01
NCGC00024890-02
NCGC00024890-03
NCGC00024890-04
NCGC00024890-05
NCGC00024890-06
NCGC00024890-07
NCGC00024890-08
NCGC00024890-09
NCGC00024890-10
NINDS_000572
NSC 15041
NSC15041
Neurelan
Neurelan (TN)
P-Aminopyridine
PYRIDINE,4-AMINO
Philips 1861
Phillips 1861
Pimadin (free base)
Prc 1237
Pymadin
Pymadine
RCRA waste no. P008
SDCCGMLS-0066228.P001
SMR000058211
SPBio_001486
SPECTRUM1501130
STK298717
Spectrum2_001413
Spectrum3_000914
Spectrum4_001013
Spectrum5_001501
Spectrum_000155
Sustained Release, 4-Aminopyridine
TL8003344
Tocris-0940
UNII-BH3B64OKL9
UPCMLD-DP125
UPCMLD-DP125:001
VMI 10-3
VMI 103
VMI-10-3
VMI-103
VMI103
WLN: T6NJ DZ
[J.Pharmacol.Exp.Ther. 275:864 (1995)]
gamma-Aminopyridine
nchem.892-comp4
p-Aminopyridine
p-Aminopyridine [UN2671] [Poison]
p-Aminopyridine [UN2671] [Poison]
pyridin-4-amine
pyridin-4-ylamine
26
Interferon beta-1aapproved, investigationalPhase 2194145258-61-36438354
Synonyms:
145258-61-3
Avonex
Avonex (TN)
Avonex Pen
Belerofon
D04554
Extavia
 
Fibroblast interferon
IFN-beta
Interferon beta precursor
Interferon beta-1a
Interferon beta-1a (USAN)
Interferon beta-1a (genetical recombination)
Interferon beta-1a (genetical recombination) (JAN)
Rebif
Rebif Rebidose
27
Folic Acidapproved, nutraceuticalPhase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
28Thioctic AcidPhase 2104
29Protective AgentsPhase 25651
30Trace ElementsPhase 23900
31Vitamin B ComplexPhase 22847
32Potassium Channel BlockersPhase 2151
33VitaminsPhase 23857
34MicronutrientsPhase 23901
35Antiviral AgentsPhase 28071
36Anti-Infective AgentsPhase 217220
37Adjuvants, ImmunologicPhase 21783
38Interferon-betaPhase 2253
39interferonsPhase 21930
40AntioxidantsPhase 22442
41Complement System ProteinsPhase 2190
42beta-endorphinPhase 299
43Melanocyte-Stimulating HormonesPhase 298
44Adrenocorticotropic HormonePhase 2133
45FolateNutraceuticalPhase 22924
46Alpha-lipoic AcidNutraceuticalPhase 2104
47Vitamin B9NutraceuticalPhase 22924
48Chelating Agents667
49Calcium, Dietary4678
50Anticoagulants1760

Interventional clinical trials:

(show top 50)    (show all 55)
idNameStatusNCT IDPhase
1Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)RecruitingNCT01757574Phase 4
2IVIg for Demyelination in Diabetes MellitusRecruitingNCT02372149Phase 4
3Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3
4Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
5Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
6Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
7Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
8Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIgCompletedNCT01349270Phase 3
9Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01184846Phase 3
10Efficacy and Safety Study of GB-0998 for Guillain-Barré SyndromeCompletedNCT02342184Phase 3
11Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDPRecruitingNCT02549170Phase 3
12Efficacy and Safety Study of I10E in Treatment of Patients With CIDPRecruitingNCT02293460Phase 3
13Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302RecruitingNCT02317562Phase 3
14Interest of Mycophenolate for CIDP WeaningRecruitingNCT02494505Phase 3
15Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré SyndromeRecruitingNCT02221271Phase 3
16Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.Active, not recruitingNCT01625182Phase 3
17Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)Active, not recruitingNCT01545076Phase 3
18Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Enrolling by invitationNCT02027701Phase 3
19Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2, Phase 3
20Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT01017159Phase 2
21Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT00099489Phase 2
22Lipoic Acid to Treat Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00962429Phase 2
23Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
24Early Mechanical Ventilation for Guillain Barré SyndromeCompletedNCT00167622Phase 2
25Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridineCompletedNCT00056810Phase 2
26Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT00278629Phase 2
27Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) PatientsRecruitingNCT02780570Phase 2
28Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome StudyRecruitingNCT02029378Phase 2
29Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyNot yet recruitingNCT02574962Phase 2
30High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
31Study of CIDP Patients During IVIG TreatmentCompletedNCT00305266
32Effect of Resistance and Aerobic Exercise in CIDP or MMNCompletedNCT02121678
33Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
34Regional Citrate Anticoagulation in Plasma Exchange TreatmentCompletedNCT01370200
35Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)CompletedNCT01306578
36Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.CompletedNCT01024088
37Brain Computer Interface for Communication in ICU: a Feasibility StudyCompletedNCT01005524
38Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT02629796
39Transcriptome Analysis of the Peripheral Blood in CIDPRecruitingNCT02404298
40sCD163 & CD19 as Candidate Biomarkers in CIDP and MMNRecruitingNCT02271724
41Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT01379833
42Subcutaneous Immunoglobulin for CIDPRecruitingNCT02465359
43IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength MeasurementsRecruitingNCT02414490
44Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyRecruitingNCT01847937
45sCD163 as a Potential Biomarker in Guillain- Barré SyndromeRecruitingNCT02582853
46International Guillain-Barré Syndrome Outcome StudyRecruitingNCT01582763
47The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin InnervationRecruitingNCT00173199
48Peristeen Bowel Irrigation System in Cauda EquinaActive, not recruitingNCT01784328
49Change of Nerve Conduction Properties in IVIg Dependent NeuropathiesActive, not recruitingNCT01655394
50Safety Study of GBS Following Menactra Meningococcal VaccinationActive, not recruitingNCT00575653

Search NIH Clinical Center for Polyradiculoneuropathy


Cochrane evidence based reviews: polyradiculoneuropathy

Genetic Tests for Polyradiculoneuropathy

About this section

Anatomical Context for Polyradiculoneuropathy

About this section

MalaCards organs/tissues related to Polyradiculoneuropathy:

33
Thyroid, Brain, T cells, Lung, Breast, Liver, Skin

Animal Models for Polyradiculoneuropathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Polyradiculoneuropathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.3ALB, CXCL12, IFNG, PRF1, STAT1, STAT3
2MP:00020068.1ALB, IFNG, PRF1, STAT1, STAT3, TBX21
3MP:00053697.7ALB, COL6A1, CXCL12, IFNG, PMP22, STAT1
4MP:00053847.0ALB, CXCL12, IFNG, MPZ, PMP22, PRF1
5MP:00053976.8CXCL12, IFNG, MAG, MPZ, PRF1, STAT1
6MP:00036316.8CXCL12, IFNG, MAG, MPZ, PMP22, PRF1
7MP:00053876.5CXCL12, IFNG, MAG, MPZ, PRF1, STAT1

Publications for Polyradiculoneuropathy

About this section

Articles related to Polyradiculoneuropathy:

(show top 50)    (show all 478)
idTitleAuthorsYear
1
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. (26873805)
2016
2
Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand. (27113227)
2016
3
Pupils in Acute Inflammatory Demyelinating Polyradiculoneuropathy Different From Adies Pupils. (26153043)
2015
4
Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. (25556954)
2015
5
Primary Neurolymphomatosis Presenting With Polyradiculoneuropathy Affecting One Lower Limb. (26301373)
2015
6
Progressive bilateral ptosis in a patient with midbrain metastasis and chronic inflammatory demyelinating polyradiculoneuropathy. (24594646)
2014
7
SjAPgren's syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT). (23503533)
2013
8
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease. (23291687)
2013
9
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment. (21922339)
2012
10
Chronic inflammatory demyelynating polyradiculoneuropathy in childhood and response to IVIg. (24391437)
2011
11
Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. (20405114)
2011
12
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. (20133204)
2010
13
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. (21040143)
2010
14
A case of acute polyradiculoneuropathy, drug-induced hypersensitivity, and HHV-6 infection. (19273829)
2009
15
Acute polyradiculoneuropathy following wasp sting. (19934578)
2009
16
Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody. (16814550)
2006
17
Chronic inflammatory demyelinating polyradiculoneuropathy: new views and guidelines. (16221282)
2005
18
Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. (15958128)
2005
19
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. (16170091)
2005
20
Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. (15372442)
2004
21
Diffuse spinal and intercostal nerve involvement in chronic inflammatory demyelinating polyradiculoneuropathy: MRI findings. (16440223)
2003
22
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. (12661048)
2003
23
Waldenstrom's Macroglobulinaemia Presenting as Demyelinating Polyradiculoneuropathy. (24326654)
2002
24
Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. (11754181)
2002
25
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. (11869620)
2002
26
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. (11222785)
2001
27
Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal [correction of letal] outcome after hepatitis B vaccination. (11412876)
2001
28
Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis. (11484826)
2001
29
Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). (10809947)
2000
30
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. (10209187)
1999
31
Acute inflammatory demyelinating polyradiculoneuropathy associated with hyperIgEemia and atopic dermatitis. (9562273)
1998
32
Anti-GQ1b and anti-GT1a IgG antibodies in a patient with acute demyelinating polyradiculoneuropathy without ophthalmoplegia. (9328270)
1997
33
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. (8936360)
1996
34
Acute inflammatory demyelinating polyradiculoneuropathy following antirabies vaccine. (9251443)
1996
35
Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. (7633875)
1995
36
Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature. (8502319)
1993
37
Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. (8451012)
1993
38
Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy. (1738011)
1992
39
Chronic inflammatory demyelinating polyradiculoneuropathy associated with Evans' syndrome. (1341469)
1992
40
Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. (1603342)
1992
41
Acquired factor VIII deficiency and polyradiculoneuropathy. (1901137)
1991
42
Evoked potentials suggest cranial nerves and CNS involvement in chronic relapsing polyradiculoneuropathy. (2731562)
1989
43
Polyradiculoneuropathy in transfusion-associated AIDS and dorsal root pathology. (2928972)
1989
44
Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. (2464267)
1988
45
Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy. (3267485)
1988
46
Fulminant leukemic polyradiculoneuropathy in a case of B-cell prolymphocytic leukemia. A clinicopathologic report. (3040217)
1987
47
Idiopathic inflammatory polyradiculoneuropathy: evaluation of clinical and laboratory data and therapeutic considerations. (6862843)
1983
48
British multicentre trial of plasma exchange in acute inflammatory polyradiculoneuropathy (AIP). (6757939)
1982
49
Polyradiculoneuropathy in Addison's disease. Case report and review of literature. (558557)
1977
50

Variations for Polyradiculoneuropathy

About this section

Expression for genes affiliated with Polyradiculoneuropathy

About this section
Search GEO for disease gene expression data for Polyradiculoneuropathy.

Pathways for genes affiliated with Polyradiculoneuropathy

About this section

Pathways related to Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 23)
idSuper pathwaysScoreTop Affiliating Genes
19.7HLA-DRB1, IFNG
2
Show member pathways
9.5IFNG, PRF1, STAT3
39.3CXCL12, HLA-DRB1, IFNG
49.3STAT1, STAT3
59.3STAT1, STAT3
69.3STAT1, STAT3
79.3STAT1, STAT3
89.2HLA-DRB1, MAG, MPZ
99.0IFNG, STAT1, STAT3
10
Show member pathways
9.0IFNG, STAT1, STAT3
11
Show member pathways
9.0IFNG, STAT1, STAT3
12
Show member pathways
9.0IFNG, STAT1, STAT3
139.0IFNG, STAT1, STAT3
148.9HLA-DRB1, IFNG, STAT1
15
Show member pathways
8.8HLA-DRB1, STAT1, STAT3
168.7IFNG, STAT1, TBX21
178.6CXCL12, IFNG, STAT1, STAT3
18
Show member pathways
8.5HLA-DRB1, IFNG, STAT1, STAT3
198.4CXCL12, HLA-DRB1, STAT1, STAT3
208.4HLA-DRB1, IFNG, PRF1, STAT3, TBX21
21
Show member pathways
8.4IFNG, STAT1, STAT3, TBX21
22
Show member pathways
7.9HLA-DRB1, IFNG, STAT1, STAT3, TBX21
23
Show member pathways
7.2CXCL12, HLA-DRB1, IFNG, PRF1, STAT1, STAT3

GO Terms for genes affiliated with Polyradiculoneuropathy

About this section

Biological processes related to Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1antigen processing and presentationGO:001988210.2HLA-DRB1, IFNG
2positive regulation of cell adhesionGO:004578510.0CXCL12, IFNG
3positive regulation of isotype switching to IgG isotypesGO:00483049.9IFNG, TBX21
4blood circulationGO:00080159.6CXCL12, STAT1
5cytokine-mediated signaling pathwayGO:00192219.2HLA-DRB1, IFNG, STAT1
6defense response to virusGO:00516079.0IFNG, PRF1, STAT1
7response to peptide hormoneGO:00434348.6CXCL12, STAT1, STAT3
8positive regulation of transcription, DNA-templatedGO:00458938.4IFNG, STAT1, STAT3, TBX21

Sources for Polyradiculoneuropathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet